Adult botryoid rhabdomyosarcoma

Summary

Adult botryoid rhabdomyosarcoma (MONDO:0004012) is a disease. A subtype of botryoid rhabdomyosarcoma — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

Field	Value
Canonical name	adult botryoid rhabdomyosarcoma
Mondo ID	MONDO:0004012
DOID	DOID:6847
NCIT	C36099
UMLS	C1332185
MedGen	231032
GARD	0023774
Is cancer (heuristic)	no

Also known as: adult botryoid sarcoma · adult botryoid-type embryonal rhabdomyosarcoma · botryoid rhabdomyosarcoma of adults

Disease family

This is a subtype of botryoid rhabdomyosarcoma. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease by etiologic mechanism › cancer or benign tumor › neoplastic disease or syndrome › neoplasm › cancer › sarcoma › soft tissue sarcoma › rhabdomyosarcoma › embryonal rhabdomyosarcoma › botryoid rhabdomyosarcoma › adult botryoid rhabdomyosarcoma

Related subtypes (2): childhood botryoid rhabdomyosarcoma, botryoid-type embryonal rhabdomyosarcoma of the vagina

Subtypes (1): adult vagina botryoid embryonal rhabdomyosarcoma

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 0.